Home
/ Opthea
/ Competitors

Opthea Competitors and Similar CompaniesClear all

Opthea's competitors and similar companies include Ocular Therapeutix and Genentech.

	Opthea Opthea (formerly Circadian Technologies) is a biopharmaceutical company developing a therapy for the treatment of retinal diseases.	Ocular Therapeutix Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Founding Date	Founding Date 2012	Founding Date 2006	Founding Date 1976
Type	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations South Yarra, AU HQ Toorak, AU	Locations Bedford, US HQ Bedford, US Bedford, US	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more
Employees	Employees 33	Employees 16740% increase	Employees 18,077
Valuation ($)	Valuation ($) 711.2 m	Valuation ($) 1.8 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $25k (FY, 2025)	Revenue (est.) $52m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $6.6m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $146k (FY, 2025)	Gross profit $45.4m (FY, 2025)	Gross profit N/A
Net income	Net income ($162.8m) (FY, 2025)	Net income ($265.9m) (FY, 2025)	Net income N/A
Operating ⚠
Phase I Trials Products	Phase I Trials Products N/A	Phase I Trials Products N/A	Phase I Trials Products 28 (Jul, 2025)
Phase II Trials Products	Phase II Trials Products 2 (FY, 2020)	Phase II Trials Products N/A	Phase II Trials Products 19 (Jul, 2025)
Funding
Total funding raised	Total funding raised $ 67.6m	Total funding raised $ 73.3m	Total funding raised N/A